Hepatitis A  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hepatitis A
NCT02031133: Long-term Extension to Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C

Active, not recruiting
2
10
US
Miravirsen
Santaris Pharma A/S
Hepatitis C
01/17
01/17

Download Options